학술논문
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Document Type
Article
Author
Bishop, M.R.; Dickinson, M.; Purtill, D.; Hamad, N.; Barba, P.; Sureda, A.; Martinez-Lopez, J.; Santoro, A.; Kato, K.; Harigae, H.; Greil, R.; Rabitsch, W.; Jäger, U.; Thieblemont, C.; Morschhauser, F.; Bachy, E.; Gouill, S.L.; Janz, M.; Dreyling, M.; Borchmann, P.; Flinn, I.; McSweeney, P.; Kwong, Y.-L.; Kersten, M.J.; Minnema, M.C.; Holte, H.; Chan, E.H.L.; Müller, A.M.S.; Newsome, S.; Degtyarev, E.; Andreola, G.; Maziarz, R.T.; McGuirk, J.P.; Bond, D.; Andreadis, C.; Kharfan-Dabaja, M.; Awasthi, R.; Del Corral, C.; Masood, A.; Schuster, S.J.; Westin, J.R.
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 17 February 2022, 386(7):629-639)
Subject
Language
English
ISSN
15334406
00284793
00284793